The Bancorp (NASDAQ:TBBK) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings

Financial services company The Bancorp (NASDAQ: TBBK) fell short of the market’s revenue expectations in Q2 CY2026, with sales falling 9.8% year on year to $163.5 million. Its GAAP profit of $1.45 per share was 6.4% above analysts’ consensus estimates. Is now the time to buy The Bancorp? Find out by accessing our full research report, it’s free.

Original reporting
Published Jul 30, 2026, 9:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 30, 2026, 9:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
The Bancorp (NASDAQ:TBBK) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings — source image
Decision brief

The 30-second read

$TBBKNeutralMed
01

Why it matters

Q2 CY2026 results show a top-line revenue miss (down 9.8% YoY to $163.5M) alongside a GAAP EPS beat ($1.45), with TBVPS growth decelerating to 4.5% over the last two years and consensus TBVPS projected to rise to $19.74 over the next 12 months.

02

Market read

Traders can reassess near-term expectations for revenue growth versus profitability, using the reported revenue miss, EPS beat, and TBVPS trajectory.

03

What to watch

The text highlights TBVPS deceleration and a revenue miss, but does not quantify credit quality, deposit costs, or guidance beyond TBVPS estimates, which could dominate the next earnings cycle.

Relevance 6/10Novelty 6/10Timing: after-hours/next-session positioning following Q2 CY2026 earnings release

Background

The Bancorp is a bank holding company serving fintech apps and prepaid cards, with revenue driven largely by net interest income.

Company-level read

Ticker impact

$TBBKNeutralMedium confidence
Context

The Bancorp reported Q2 CY2026 revenue of $163.5M, down 9.8% YoY and below analyst estimates, while GAAP EPS was $1.45.

Expected impact

Near-term downside bias versus revenue expectations, with support possible if investors focus on profitability outperformance.

Evidence & confidence

The article provides a concrete revenue miss versus estimates and a GAAP EPS beat, plus notes the stock was flat at $64.81 immediately after results, implying limited immediate repricing but ongoing debate on growth durability.

Market effects

Read-through for fintech-focused banking models: investors may scrutinize net interest income stability versus non-interest and overall revenue growth.

No specific regional macro linkage provided beyond general banking performance.

Limited, article is company-specific with no cross-border deal or regulatory shock.

Counterpoint

Investors may treat the revenue decline as temporary while emphasizing profitability momentum and net interest income resilience.

Key entities

  • The Bancorp

    NASDAQ-listed bank holding company reporting Q2 CY2026 earnings with revenue below estimates and GAAP EPS above consensus.

  • Damian Kozlowski

    President and CEO quoted on profitability and GDV growth momentum into the second half of the year.

Related articles

$TBBKMedAI 8/10

Bancorp (TBBK) Q2 2026 Earnings Call Transcript

Bancorp (TBBK) discussed its Q2 2026 earnings call, citing fintech GDV growth of 22.5% YoY and fintech revenue growth of 21% YoY. The company raised full-year 2026 EPS guidance to $5.95 to $6.05, with Q4 2026 EPS guidance of $1.65 to $1.75 and 2027 EPS guidance of $8.10 to $8.30. It forecast $200M buybacks in 2026.

$TBBKMed

Why The Bancorp Stock Popped Again Today

The Bancorp (TBBK) shares rose nearly 7% on Monday after two analysts raised price targets following its Q2 earnings. Piper Sandler’s Manuel Navas lifted fair value to $86 from $70 and kept an overweight rating, citing guidance for double-digit EPS growth and ongoing share repurchases. Keefe, Bruyette & Woods raised its target to $79 from $77 and kept a buy-equivalent rating.

$TBBKMed

Why The Bancorp Stock Beat the Market on Friday

The Bancorp (TBBK) rose about 3.5% on Friday after its Q2 results showed a bottom-line beat and raised full-year GAAP earnings guidance. Revenue was $163.5M vs $166.7M expected. GAAP net income was under $60.7M, about $1.45/share. Full-year guidance increased to $5.95-$6.05/share.

$TBBKMed

Bancorp, Inc. (TBBK): Results of Operations and Financial Condition

Bancorp, Inc. (TBBK) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tbbk-20260730xexx991.htm EX-99.1 Document Exhibit 99.1 THE BANCORP REPORTS 2Q 2026 EPS OF $1.45, ROA OF 2.51%, AND ROE OF 34.7% DRIVEN BY STRONG GROWTH IN LOANS AND FINTECH FEES; CONTINUED IMPROVEMENT IN CREDIT AND COST EFFICIENCIES Second Quarter 2026 Highlights • Earn

$TBBKMed

Why The Bancorp Stock Surged Today

The Bancorp (NASDAQ: TBBK) shares rose nearly 8% on Thursday after Keefe, Bruyette & Woods upgraded the stock. Analyst Timothy Switzer raised his rating to “outperform” from “market perform,” citing The Bancorp’s shift toward third-party banking services and expectations it can meet management’s guidance, with potential for higher growth versus traditional peers.

$DTMedAI 8/10

Dynatrace Springs on Q1 Figures

Dynatrace (NYSE: DT) reported Q1 FY2027 results for the quarter ended June 30, 2026. Total ARR was $2,136 million, up 17%. Total revenue rose to $555 million, up 16%. Subscription revenue was $530 million. GAAP operating income was $71 million and non-GAAP $162 million. CEO Rick McConnell cited 41% organic net new ARR growth and accelerating TTM growth.